Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of rare diseases. Eiger has built a diverse, late-stage portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, a novel biology for treatment has been identified, and for which an effective therapy is urgently needed. The Eiger management team has extensive experience in the clinical development a... More >>
|Data as of Oct 19, 2019 3:50 PM EDT
Recent NewsMore >>
Upcoming EventsMore >>
|Friday, November 08, 2019 through Tuesday, November 12, 2019||
|Wednesday, November 20, 2019 through Thursday, November 21, 2019||
There are currently no items available.